Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04955795 · ClinicalTrials.gov registry record · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
A NA study of HIV and Alcohol Problem, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 308
- Enrollment target
- 5
- Study locations
NCT04955795: Recruiting NA study of HIV and Alcohol Problem, sponsored by University of Alabama at Birmingham.
NCT04955795 is a NA study of HIV and Alcohol Problem that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 308 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04955795, a NA study of HIV and Alcohol Problem, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 308 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is designed to examine the efficacy of a brief intervention plus a cognitive-behavioral intervention compared to brief intervention alone to address unhealthy alcohol use and comorbid mental health symptoms to improve HIV outcomes among people living with HIV in Alabama.
Primary Outcome
Defined by the participant's score on the Alcohol Use Disorders Identification Test (AUDIT). The minimum score on the AUDIT measure is 0, and the maximum score on the AUDIT measure is 40. For women, a score of of 4 or greater indicates hazardous or harmful alcohol consumption. For men, a score of 8 or greater indicates hazardous or harmful alcohol consumption. Higher scores on the AUDIT measure indicates more hazardous or harmful alcohol consumption. This outcome will be the change in AUDIT from
Conditions Studied
Interventions
- BEHAVIORAL Alcohol Brief Intervention (BI)
- BEHAVIORAL Common Elements Treatment Approach (CETA) via Telemedicine
Study Locations (5)
Alabama
- Health Service Center - Anniston
- UAB Family Clinic - Birmingham
- Thrive - Huntsville
- Five Horizons - Montgomery
- Unity Wellness - Opelika
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT04955795 shows while recruiting
NCT04955795 is an interventional study that assigns participants to a tested intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Alcohol Brief Intervention (BI) is the first listed.
NCT04955795 lists 5 locations in 1 state (Alabama).
Frequently Asked Questions
What is clinical trial NCT04955795 about?
NCT04955795 is a clinical study titled "Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA". This study is designed to examine the efficacy of a brief intervention plus a cognitive-behavioral intervention compared to brief intervention alone to address unhealthy alcohol use and comorbid mental health symptoms to improve HIV outcomes among people living with HIV in Alabama.
What is the current status of trial NCT04955795?
This trial is currently recruiting. It is a NA study. The enrollment target is 308 participants. The study started on 2023-05-04. Estimated completion is 2027-09-30.
What conditions does trial NCT04955795 study?
This clinical trial studies the following conditions: HIV, Alcohol Problem.
What interventions are being tested in trial NCT04955795?
The interventions under investigation include: Alcohol Brief Intervention (BI) (BEHAVIORAL), Common Elements Treatment Approach (CETA) via Telemedicine (BEHAVIORAL).
Who is sponsoring clinical trial NCT04955795?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04955795 being conducted?
This trial has 5 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04955795's enrollment target sits among peer trials
308 68th of 303 higher than 236 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
- NCT06319248 · 308 participants · Phase 2
MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI